| Sandra Y Suderman, ARNP | |
|
913 Sheidley Ave, Bonner Springs, KS 66012-9514 | |
| (913) 322-7222 | |
| (913) 322-7284 |
| Full Name | Sandra Y Suderman |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 27 Years |
| Location | 913 Sheidley Ave, Bonner Springs, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679666077 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 44574 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Medical Center | Kansas city, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Prime Healthcare Physician Services - Providence Inc | 1052553906 | 62 |
News Archive
BioSpec Global Solutions Inc., and partner -ICBS Ltd., announced today that it has begun development of three new bio filter for the testing of E. coli, salmonella, listeria and pseudomonas in food samples. Development of the Antibody/antigen multiple discrete filters and optical system for the simultaneous analysis of E.coli, salmonella, listeria and pseudomonas in food samples.
By measuring the total gene activity in organs relevant for coronary artery disease (CAD), scientists at the Swedish medical university Karolinska Institutet have identified a module of genes that is important for the recruitment of white blood cells into the atherosclerotic plaque.
The UK has one of the highest rates of death for children under five in western Europe, according to new research published in The Lancet.
Opexa Therapeutics, Inc., a company developing Tovaxin, a novel T-cell therapy for multiple sclerosis, today presented important efficacy data at the American Academy of Neurology 63rd Annual Meeting.
› Verified 3 days ago
| Entity Name | Prime Healthcare Physician Services - Providence Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356683213 PECOS PAC ID: 1052553906 Enrollment ID: O20130806000598 |
News Archive
BioSpec Global Solutions Inc., and partner -ICBS Ltd., announced today that it has begun development of three new bio filter for the testing of E. coli, salmonella, listeria and pseudomonas in food samples. Development of the Antibody/antigen multiple discrete filters and optical system for the simultaneous analysis of E.coli, salmonella, listeria and pseudomonas in food samples.
By measuring the total gene activity in organs relevant for coronary artery disease (CAD), scientists at the Swedish medical university Karolinska Institutet have identified a module of genes that is important for the recruitment of white blood cells into the atherosclerotic plaque.
The UK has one of the highest rates of death for children under five in western Europe, according to new research published in The Lancet.
Opexa Therapeutics, Inc., a company developing Tovaxin, a novel T-cell therapy for multiple sclerosis, today presented important efficacy data at the American Academy of Neurology 63rd Annual Meeting.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sandra Y Suderman, ARNP 913 Sheidley Ave, Bonner Springs, KS 66012-9514 Ph: (913) 322-7222 | Sandra Y Suderman, ARNP 913 Sheidley Ave, Bonner Springs, KS 66012-9514 Ph: (913) 322-7222 |
News Archive
BioSpec Global Solutions Inc., and partner -ICBS Ltd., announced today that it has begun development of three new bio filter for the testing of E. coli, salmonella, listeria and pseudomonas in food samples. Development of the Antibody/antigen multiple discrete filters and optical system for the simultaneous analysis of E.coli, salmonella, listeria and pseudomonas in food samples.
By measuring the total gene activity in organs relevant for coronary artery disease (CAD), scientists at the Swedish medical university Karolinska Institutet have identified a module of genes that is important for the recruitment of white blood cells into the atherosclerotic plaque.
The UK has one of the highest rates of death for children under five in western Europe, according to new research published in The Lancet.
Opexa Therapeutics, Inc., a company developing Tovaxin, a novel T-cell therapy for multiple sclerosis, today presented important efficacy data at the American Academy of Neurology 63rd Annual Meeting.
› Verified 3 days ago
Patty L. Gerken, ANP-BC, AOCN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 115 E Spring Ave, Bonner Springs, KS 66012 Phone: 913-638-6768 | |
Mrs. Jamie Marie Magana, NP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 16181 150th St, Bonner Springs, KS 66012 Phone: 620-704-2215 | |
Alexis Chaney, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 128 Oak St Ste C, Bonner Springs, KS 66012 Phone: 913-348-6280 | |
Melanie Miller, APRN- BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 128 Oak St Ste C, Bonner Springs, KS 66012 Phone: 877-942-8808 Fax: 877-791-9808 |